Vitamin E decreases bone mass by stimulating osteoclast fusion
Koji Fujita(Tokyo Medical and Dental University), Shu Takeda(Toranomon Hospital), Chengshan Ma(Tokyo Medical and Dental University), Atsushi Okawa(Research Institute of Economy, Trade and Industry), Kimitaka Takitani(Osaka Medical and Pharmaceutical University), Hiroyuki Arai(The University of Tokyo), Satoko Sunamura(Tokyo Medical and Dental University), Makiko Iwasaki(Tokyo Medical and Dental University), Hiroshi Itoh(Keio University), Takako Negishi‐Koga(Juntendo University), Hiroki Ochi(National Rehabilitation Center for Persons with Disabilities), Tatsuhiko Kodama(The University of Tokyo), Hiroshi Takayanagi(Tokyo Medical and Dental University), Kenichi Shinomiya(Yokohama Municipal Minato Red Cross Hospital), Hiroshi Tamai(Yodogawa Christian Hospital), Shigeaki Kato(Fukushima Medical University), Toru Fukuda(Saitama Medical University), Takeshi Miyamoto(Kumamoto Health Science University)
Cited by 174
Related Papers
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
|The Journal of Cell Biology|2002|944
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694